Detalles de la búsqueda
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290468
2.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36329397
3.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013967
4.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511059
5.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30665378
6.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29501366
7.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30594171
8.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572856
9.
Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Eur J Cancer
; 163: 26-34, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032814
10.
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
J Clin Oncol
; 40(11): 1163-1173, 2022 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990291
11.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol
; 160: 9-17, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839205
12.
Efficacy of Transnasal Endoscopic Fine-Needle Aspiration Biopsy in Diagnosing Submucosal Nasopharyngeal Carcinoma.
Laryngoscope
; 131(8): 1798-1804, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616259
13.
Geriatric nutritional risk index as an independent prognostic factor in locally advanced nasopharyngeal carcinoma treated using radical concurrent chemoradiotherapy: a retrospective cohort study.
Ann Transl Med
; 9(7): 532, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33987230
14.
Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients.
Front Oncol
; 10: 378, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32266152
15.
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma.
J Immunother Cancer
; 8(1)2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32303611
16.
Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.
Oral Oncol
; 92: 40-45, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010621
17.
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
Cancer Res Treat
; 51(4): 1259-1268, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653745
18.
The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study.
Cancer Manag Res
; 11: 6253-6263, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31372033
19.
The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012.
Int J Radiat Oncol Biol Phys
; 105(3): 581-590, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31319091
20.
The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Cancer Commun (Lond)
; 39(1): 14, 2019 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30925939